54,065 Omega Healthcare Investors, Inc. $OHI Shares Sold by Cornerstone Enterprises LLC

Cornerstone Enterprises LLC decreased its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 26.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 148,326 shares of the real estate investment trust’s stock after selling 54,065 shares during the period. Omega Healthcare Investors accounts for 4.2% of Cornerstone Enterprises LLC’s portfolio, making the stock its 7th largest position. Cornerstone Enterprises LLC’s holdings in Omega Healthcare Investors were worth $6,869,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in OHI. BlackRock Inc. acquired a new stake in Omega Healthcare Investors in the second quarter worth $1,838,155,000. Bank of New York Mellon Corp bought a new stake in Omega Healthcare Investors in the second quarter valued at $275,230,000. Dimensional Fund Advisors LP lifted its stake in Omega Healthcare Investors by 2.5% in the first quarter. Dimensional Fund Advisors LP now owns 4,423,120 shares of the real estate investment trust’s stock valued at $193,824,000 after buying an additional 108,736 shares during the last quarter. Bank of America Corp DE lifted its stake in Omega Healthcare Investors by 3.6% in the first quarter. Bank of America Corp DE now owns 3,794,730 shares of the real estate investment trust’s stock valued at $166,285,000 after buying an additional 131,000 shares during the last quarter. Finally, Quantinno Capital Management LP lifted its stake in Omega Healthcare Investors by 48.5% in the first quarter. Quantinno Capital Management LP now owns 2,125,931 shares of the real estate investment trust’s stock valued at $93,158,000 after buying an additional 694,426 shares during the last quarter. Institutional investors and hedge funds own 65.25% of the company’s stock.

Omega Healthcare Investors Price Performance

Shares of OHI stock opened at $45.51 on Friday. Omega Healthcare Investors, Inc. has a 12-month low of $39.26 and a 12-month high of $52.39. The firm has a market capitalization of $13.79 billion, a price-to-earnings ratio of 16.25, a price-to-earnings-growth ratio of 1.82 and a beta of 0.53. The business has a 50 day simple moving average of $46.30 and a 200 day simple moving average of $46.92.

Omega Healthcare Investors (NYSE:OHI) last posted its earnings results on Wednesday, July 29th. The real estate investment trust reported $1.19 EPS for the quarter, beating the consensus estimate of $0.51 by $0.68. The firm had revenue of $328.25 million for the quarter, compared to analysts’ expectations of $266.97 million. Omega Healthcare Investors had a return on equity of 15.76% and a net margin of 66.96%. The firm’s revenue was up 16.2% compared to the same quarter last year. During the same period last year, the firm earned $0.77 EPS. Omega Healthcare Investors has set its FY 2026 guidance at 3.220-3.260 EPS. On average, equities analysts anticipate that Omega Healthcare Investors, Inc. will post 3.12 EPS for the current fiscal year.

Omega Healthcare Investors Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 14th. Stockholders of record on Monday, August 3rd were paid a $0.68 dividend. The ex-dividend date of this dividend was Monday, August 3rd. This is a positive change from Omega Healthcare Investors’s previous quarterly dividend of $0.67. This represents a $2.72 annualized dividend and a dividend yield of 6.0%. Omega Healthcare Investors’s dividend payout ratio (DPR) is currently 97.14%.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on OHI. Mizuho boosted their price target on shares of Omega Healthcare Investors from $45.00 to $46.00 and gave the company a “neutral” rating in a report on Monday, August 31st. Barclays dropped their price objective on shares of Omega Healthcare Investors from $50.00 to $48.00 and set an “underweight” rating on the stock in a report on Tuesday. Raymond James Financial reaffirmed an “outperform” rating and issued a $53.00 price objective on shares of Omega Healthcare Investors in a report on Tuesday, October 6th. Scotiabank cut their price objective on shares of Omega Healthcare Investors from $50.00 to $47.00 and set a “sector perform” rating on the stock in a research report on Thursday, June 18th. Finally, Weiss Ratings reissued a “buy (b+)” rating on shares of Omega Healthcare Investors in a research note on Friday, September 25th. Six investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $49.93.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) focused on healthcare facilities, with an emphasis on skilled nursing and assisted living properties. The company owns or invests in healthcare real estate and leases its properties to operators that provide care and related services to residents.

Omega generally uses long-term, predominantly triple-net lease arrangements, under which tenants are responsible for many property-level expenses, including maintenance, insurance and taxes.